Literature DB >> 11597972

The case against aggressive treatment of type 2 diabetes: critique of the UK prospective diabetes study.

R M Ewart1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11597972      PMCID： PMC1121393          DOI： 10.1136/bmj.323.7317.854

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  18 in total

1.  UKPDS: what was the question? UK Prospective Diabetes Study.

Authors:  R Turner; R Holman; J Butterfield
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

Review 2.  The agonising negative trend in monitoring of clinical trials.

Authors:  D L DeMets; S J Pocock; D G Julian
Journal:  Lancet       Date:  1999-12-04       Impact factor: 79.321

3.  Screening for type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2000-01       Impact factor: 19.112

Review 4.  Insulin use in NIDDM. Rationale based on pathophysiology of disease.

Authors:  R C Turner; R R Holman
Journal:  Diabetes Care       Date:  1990-09       Impact factor: 19.112

5.  [The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results].

Authors:  J C Levy; C A Cull; I M Stratton; R R Holman; R C Turner
Journal:  Journ Annu Diabetol Hotel Dieu       Date:  1993

6.  UK prospective study of therapies of maturity-onset diabetes.

Authors:  R C Turner; J I Mann; R Peto
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

7.  UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year.

Authors: 
Journal:  Diabetologia       Date:  1983-06       Impact factor: 10.122

8.  UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.

Authors: 
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122

9.  United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years.

Authors: 
Journal:  BMJ       Date:  1995-01-14

10.  Diabetes: The quest for basal normoglycaemia.

Authors:  R R Holman; R C Turner
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321
View more
  10 in total

Review 1.  Evidence, values, guidelines and rational decision-making.

Authors:  Bruce Barrett
Journal:  J Gen Intern Med       Date:  2011-10-05       Impact factor: 5.128

Review 2.  What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetes.

Authors:  Allen F Shaughnessy; David C Slawson
Journal:  BMJ       Date:  2003-08-02

3.  Cost-effectiveness of insulin analogues for diabetes mellitus.

Authors:  Chris G Cameron; Heather A Bennett
Journal:  CMAJ       Date:  2009-02-17       Impact factor: 8.262

Review 4.  Pioglitazone for type 2 diabetes mellitus.

Authors:  B Richter; E Bandeira-Echtler; K Bergerhoff; C Clar; S H Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

5.  Efficacy of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin: a systematic review and meta-analysis.

Authors:  Brendan McIntosh; Changhua Yu; Avtar Lal; Kristen Chelak; Chris Cameron; Sumeet R Singh; Marshall Dahl
Journal:  Open Med       Date:  2010-05-18

6.  Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.

Authors:  Rémy Boussageon; Irène Supper; Theodora Bejan-Angoulvant; Nadir Kellou; Michel Cucherat; Jean-Pierre Boissel; Behrouz Kassai; Alain Moreau; François Gueyffier; Catherine Cornu
Journal:  PLoS Med       Date:  2012-04-10       Impact factor: 11.069

7.  Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials.

Authors:  Sylvie Erpeldinger; Michaela B Rehman; Christophe Berkhout; Christophe Pigache; Yves Zerbib; Francis Regnault; Emilie Guérin; Irène Supper; Catherine Cornu; Behrouz Kassaï; François Gueyffier; Rémy Boussageon
Journal:  BMC Endocr Disord       Date:  2016-07-08       Impact factor: 2.763

Review 8.  Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus.

Authors:  B Richter; E Bandeira-Echtler; K Bergerhoff; C L Lerch
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

Review 9.  Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes.

Authors:  Bernd Richter; Elizabeth Bandeira-Echtler; Karla Bergerhoff; Christian Lerch
Journal:  Vasc Health Risk Manag       Date:  2008

Review 10.  Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review.

Authors:  Rémy Boussageon; Irène Supper; Sylvie Erpeldinger; Michel Cucherat; Theodora Bejan-Angoulvant; Behrouz Kassai; Catherine Cornu; François Gueyffier
Journal:  BMC Med Res Methodol       Date:  2013-08-30       Impact factor: 4.615
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.